Меню
Идёт набор NCT05783466

Dairy Lipids and Cardiometabolic Risk

Без фазы С лечением Morbid Obesity

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Low-fat dairy products, Whole-fat dairy products, Milk polar lipid enriched whole-fat dairy products.
Кому может быть актуально
Состояния в реестре: Morbid Obesity. Базовые параметры: 18 лет — 70 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Франция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Bioactive Dairy Lipids to Manage Cardiometabolic Risk in Obesity

Обзор

It is a randomized parallel arm intervention study in adults with severe obesity. The objective is to demonstrate that within a dietary handling for weight loss, the daily ingestion during 3 months of whole dairy products enriched with milk polar lipids or whole dairy products decreases to a greater extent fasting plasma apolipoprotein B concentrations than the daily ingestion of low-fat dairy products (control group). Metabolic parameters will be assessed before and after the 3-month intervention, both at fasting and in postprandial period after the consumption of standardized meals.

Вмешательства

  • Другое Low-fat dairy products
    3-month intervention
  • Другое Whole-fat dairy products
    3-month intervention
  • Другое Milk polar lipid enriched whole-fat dairy products
    3-month intervention

Первичные конечные точки

  • Total plasma apolipoprotein B concentration [Срок оценки: day 0 and day 90]
Вторичные конечные точки (12)
  • Changes in weight [Срок оценки: day 0 and day 90]
  • Anthropometric measurements 2 [Срок оценки: day 0 and day 90]
  • Body mass composition measurements [Срок оценки: day 0 and day 90]
  • Plasma lipid concentrations after 3-month intervention, measured using standard laboratory methods [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. • For postprandial measurements: times 60 minutes-120 minutes -180 minutes -240 minutes -270 minutes -300 minutes -360 minutes]
  • Plasma lipid concentrations after 3-month intervention, measured using standard laboratory methods 2 [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. For postprandial measurements: times 120 minutes -180 minutes -240 minutes -270 minutes -300 minutes.]
  • Plasma lipid concentrations after 3-month intervention, measured using standard laboratory methods 3 [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. For postprandial measurements: time 360 minutes.]
  • Plasma lipid concentrations after 3-month intervention, measured using standard laboratory methods 4 [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. For postprandial measurements: time 360 minutes.]
  • Plasma lipid concentrations after 3-month intervention, measured using standard laboratory methods 5 [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. For postprandial measurements: times 120 minutes -240 minutes -300 minutes.]
  • Plasma lipid concentrations after 3-month intervention, measured using standard laboratory methods 6 [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. For postprandial measurements: times 120 minutes -240 minutes -300 minutes - 360 minutes]
  • Plasma lipid concentrations after 3-month intervention, measured using standard laboratory methods 7 [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. For postprandial measurements:times 360 minutes.]
  • Plasma lipid concentrations after 3-month intervention, measured using standard laboratory methods 8 [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. For postprandial measurements: times 120 minutes -240 minutes]
  • Glucose concentrations after 3-month intervention, measured using standard laboratory methods [Срок оценки: day 0 and day 90 for fasting and postprandial measurements. For postprandial measurements: times 120 minutes -240 minutes]

Критерии участия

Критерии включения

  • Men and women between 18-70 years
  • Body Mass Index (BMI) between 35 and 60 kg/m2 inclusive
  • Stable body weight (weight change +/- 5 % for 3 months prior to screening)
  • Consumption of at least 1 serving/day of dairy products made from cow's milk
  • Informed consent

Критерии исключения

  • History of bariatric or digestive surgery or disease interfering with main outcomes
  • Drinking more than 3 glasses of alcohol per day (>30g/day)
  • Pregnancy, parturiency or breastfeeding
  • Food allergies or intolerance to dairy products
  • Dietary restriction (vegetarian or lactovegetarian) or high protein diet
  • Use of dietary supplements
  • Treated with lipid lowering drugs (fibrates, statins, anti-PCSK9, ezetimibe, cholestyramine) within the last 6 weeks before study entry
  • Treated with insulin, GLP-1 analogs, acarbose, corticoids, beta-blockers.
  • Medications interfering with intestinal microbiota (beta-lactamines within 3 months before the study or laxatives)
  • Smoking ≥ 5 cigarettes/day during the past 6 months.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Другое

Центры проведения

Франция · 2 центра
  • Centre de Recherche en Nutrition Humaine Rhône-Alpes — Pierre-Bénite
  • Centres Hospitalier Lyon Sud, Service d'Endocrinologie-Diabète-Nutrition — Pierre-Bénite

Идентификаторы

NCT: NCT05783466 · 69HCL22_0461 · 2022-A02415-38

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗